Article citationsMore>>

Nieto, Y., Nawaz, S. and Cagnoni, P.J. (1999) Overexpression of Her 2/Neu (H2N), But Not P53 Mutations Is a Poor Prognostic Factor of High-Risk Primary Breast Cancer (HRPBC) Treated with High-Dose Chemotherapy (HDC) and Autologous Stem-Cell Transplant (ASCT). Proceedings of American Society of Clinical Oncology, 18, Abstract 290.

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top